aluates Reports

$ 0.0

Automative

Coagulation Factor VIIa - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-29K12025

Global Coagulation Factor VIIa Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Coagulation Factor VIIa - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-29K12025

Report

September 2024

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novo Nordisk

LFB SA HEMA Biologics

AryoGen Pharmed

Generium

Coagulation Factor VIIa - Market Size

The global market for Coagulation Factor VIIa was estimated to be worth US$ 1179.9 million in 2023 and is forecast to a readjusted size of US$ 1529.8 million by 2030 with a CAGR of 3.7% during the forecast period 2024-2030

Coagulation Factor VIIa - Market

Recombinant activated factor VII (rFVIIa) binds to exposed tissue factor at the place of tissue and vascular injury. Thrombin generated by this process activates platelets and the coagulation cascade.

Due to the COVID-19 pandemic, the global Recombinant Human Coagulation VIIa market size is estimated to be worth US$ 1180 million in 2022 and is forecast to a readjusted size of US$ 1467 million by 2028 with a CAGR of 3.7% during the forecast period 2022-2028. Market driver is mainly rising number of hemophilia patients across the world. Recombinant coagulation factors, as opposed to plasma-derived counterparts, consume a very low risk for transfer of infectious diseases and their use would eliminate the risk of infection from viruses such as the human immunodeficiency virus and hepatitis C. The advancement of recombinant coagulation factors has been a major importance in hemophilia care promising nearly complete safety of individuals from the risk of transmitted infections.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Coagulation Factor VIIa, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Coagulation Factor VIIa by region & country, by Type, and by Application.

The Coagulation Factor VIIa market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coagulation Factor VIIa.

Market Segmentation

Scope of Coagulation Factor VIIa - Market Report

Report Metric	Details
Report Name	Coagulation Factor VIIa - Market
Forecasted market size in 2028	US$ 1467 million
CAGR	3.7%
Forecasted years	2024 - 2028
Segment by Type:	Prefilled Syringe Vial
Segment by Application	Congenital Hemophilia Acquired Hemophilia Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novo Nordisk, LFB SA HEMA Biologics, AryoGen Pharmed, GENERIUM
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Coagulation Factor VIIa manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Coagulation Factor VIIa in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Coagulation Factor VIIa in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Coagulation Factor VIIa - Market size in 2028?

Ans: The Coagulation Factor VIIa - Market size in 2028 will be US$ 1467 million.

Who are the main players in the Coagulation Factor VIIa - Market report?

Ans: The main players in the Coagulation Factor VIIa - Market are Novo Nordisk, LFB SA HEMA Biologics, AryoGen Pharmed, GENERIUM

What are the Application segmentation covered in the Coagulation Factor VIIa - Market report?

Ans: The Applications covered in the Coagulation Factor VIIa - Market report are Congenital Hemophilia, Acquired Hemophilia, Other

What are the Type segmentation covered in the Coagulation Factor VIIa - Market report?

Ans: The Types covered in the Coagulation Factor VIIa - Market report are Prefilled Syringe, Vial

Recommended Reports

Coagulation Factors

Hemostasis Devices

Diagnostic Analyzers

1 Market Overview

1.1 Coagulation Factor VIIa Product Introduction

1.2 Global Coagulation Factor VIIa Market Size Forecast

1.2.1 Global Coagulation Factor VIIa Sales Value (2019-2030)

1.2.2 Global Coagulation Factor VIIa Sales Volume (2019-2030)

1.2.3 Global Coagulation Factor VIIa Sales Price (2019-2030)

1.3 Coagulation Factor VIIa Market Trends & Drivers

1.3.1 Coagulation Factor VIIa Industry Trends

1.3.2 Coagulation Factor VIIa Market Drivers & Opportunity

1.3.3 Coagulation Factor VIIa Market Challenges

1.3.4 Coagulation Factor VIIa Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Coagulation Factor VIIa Players Revenue Ranking (2023)

2.2 Global Coagulation Factor VIIa Revenue by Company (2019-2024)

2.3 Global Coagulation Factor VIIa Players Sales Volume Ranking (2023)

2.4 Global Coagulation Factor VIIa Sales Volume by Company Players (2019-2024)

2.5 Global Coagulation Factor VIIa Average Price by Company (2019-2024)

2.6 Key Manufacturers Coagulation Factor VIIa Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Coagulation Factor VIIa Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Coagulation Factor VIIa

2.9 Coagulation Factor VIIa Market Competitive Analysis

2.9.1 Coagulation Factor VIIa Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Coagulation Factor VIIa Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coagulation Factor VIIa as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Prefilled Syringe

3.1.2 Vial

3.2 Global Coagulation Factor VIIa Sales Value by Type

3.2.1 Global Coagulation Factor VIIa Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Coagulation Factor VIIa Sales Value, by Type (2019-2030)

3.2.3 Global Coagulation Factor VIIa Sales Value, by Type (%) (2019-2030)

3.3 Global Coagulation Factor VIIa Sales Volume by Type

3.3.1 Global Coagulation Factor VIIa Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Coagulation Factor VIIa Sales Volume, by Type (2019-2030)

3.3.3 Global Coagulation Factor VIIa Sales Volume, by Type (%) (2019-2030)

3.4 Global Coagulation Factor VIIa Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Congenital Hemophilia

4.1.2 Acquired Hemophilia

4.1.3 Other

4.2 Global Coagulation Factor VIIa Sales Value by Application

4.2.1 Global Coagulation Factor VIIa Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Coagulation Factor VIIa Sales Value, by Application (2019-2030)

4.2.3 Global Coagulation Factor VIIa Sales Value, by Application (%) (2019-2030)

4.3 Global Coagulation Factor VIIa Sales Volume by Application

4.3.1 Global Coagulation Factor VIIa Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Coagulation Factor VIIa Sales Volume, by Application (2019-2030)

4.3.3 Global Coagulation Factor VIIa Sales Volume, by Application (%) (2019-2030)

4.4 Global Coagulation Factor VIIa Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Coagulation Factor VIIa Sales Value by Region

5.1.1 Global Coagulation Factor VIIa Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Coagulation Factor VIIa Sales Value by Region (2019-2024)

5.1.3 Global Coagulation Factor VIIa Sales Value by Region (2025-2030)

5.1.4 Global Coagulation Factor VIIa Sales Value by Region (%), (2019-2030)

5.2 Global Coagulation Factor VIIa Sales Volume by Region

5.2.1 Global Coagulation Factor VIIa Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Coagulation Factor VIIa Sales Volume by Region (2019-2024)

5.2.3 Global Coagulation Factor VIIa Sales Volume by Region (2025-2030)

5.2.4 Global Coagulation Factor VIIa Sales Volume by Region (%), (2019-2030)

5.3 Global Coagulation Factor VIIa Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Coagulation Factor VIIa Sales Value, 2019-2030

5.4.2 North America Coagulation Factor VIIa Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Coagulation Factor VIIa Sales Value, 2019-2030

5.5.2 Europe Coagulation Factor VIIa Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Coagulation Factor VIIa Sales Value, 2019-2030

5.6.2 Asia Pacific Coagulation Factor VIIa Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Coagulation Factor VIIa Sales Value, 2019-2030

5.7.2 South America Coagulation Factor VIIa Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Coagulation Factor VIIa Sales Value, 2019-2030

5.8.2 Middle East & Africa Coagulation Factor VIIa Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Coagulation Factor VIIa Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Coagulation Factor VIIa Sales Value

6.2.1 Key Countries/Regions Coagulation Factor VIIa Sales Value, 2019-2030

6.2.2 Key Countries/Regions Coagulation Factor VIIa Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Coagulation Factor VIIa Sales Value, 2019-2030

6.3.2 United States Coagulation Factor VIIa Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Coagulation Factor VIIa Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Coagulation Factor VIIa Sales Value, 2019-2030

6.4.2 Europe Coagulation Factor VIIa Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Coagulation Factor VIIa Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Coagulation Factor VIIa Sales Value, 2019-2030

6.5.2 China Coagulation Factor VIIa Sales Value by Type (%), 2023 VS 2030

6.5.3 China Coagulation Factor VIIa Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Coagulation Factor VIIa Sales Value, 2019-2030

6.6.2 Japan Coagulation Factor VIIa Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Coagulation Factor VIIa Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Coagulation Factor VIIa Sales Value, 2019-2030

6.7.2 South Korea Coagulation Factor VIIa Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Coagulation Factor VIIa Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Coagulation Factor VIIa Sales Value, 2019-2030

6.8.2 Southeast Asia Coagulation Factor VIIa Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Coagulation Factor VIIa Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Coagulation Factor VIIa Sales Value, 2019-2030

6.9.2 India Coagulation Factor VIIa Sales Value by Type (%), 2023 VS 2030

6.9.3 India Coagulation Factor VIIa Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Novo Nordisk

7.1.1 Novo Nordisk Company Information

7.1.2 Novo Nordisk Introduction and Business Overview

7.1.3 Novo Nordisk Coagulation Factor VIIa Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Novo Nordisk Coagulation Factor VIIa Product Offerings

7.1.5 Novo Nordisk Recent Development

7.2 LFB SA HEMA Biologics

7.2.1 LFB SA HEMA Biologics Company Information

7.2.2 LFB SA HEMA Biologics Introduction and Business Overview

7.2.3 LFB SA HEMA Biologics Coagulation Factor VIIa Sales, Revenue and Gross Margin (2019-2024)

7.2.4 LFB SA HEMA Biologics Coagulation Factor VIIa Product Offerings

7.2.5 LFB SA HEMA Biologics Recent Development

7.3 AryoGen Pharmed

7.3.1 AryoGen Pharmed Company Information

7.3.2 AryoGen Pharmed Introduction and Business Overview

7.3.3 AryoGen Pharmed Coagulation Factor VIIa Sales, Revenue and Gross Margin (2019-2024)

7.3.4 AryoGen Pharmed Coagulation Factor VIIa Product Offerings

7.3.5 AryoGen Pharmed Recent Development

7.4 GENERIUM

7.4.1 GENERIUM Company Information

7.4.2 GENERIUM Introduction and Business Overview

7.4.3 GENERIUM Coagulation Factor VIIa Sales, Revenue and Gross Margin (2019-2024)

7.4.4 GENERIUM Coagulation Factor VIIa Product Offerings

7.4.5 GENERIUM Recent Development

8 Industry Chain Analysis

8.1 Coagulation Factor VIIa Industrial Chain

8.2 Coagulation Factor VIIa Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Coagulation Factor VIIa Sales Model

8.5.2 Sales Channel

8.5.3 Coagulation Factor VIIa Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Novo Nordisk

LFB SA HEMA Biologics

AryoGen Pharmed

Generium

List of Tables

Table 1. Coagulation Factor VIIa Market Trends

Table 2. Coagulation Factor VIIa Market Drivers & Opportunity

Table 3. Coagulation Factor VIIa Market Challenges

Table 4. Coagulation Factor VIIa Market Restraints

Table 5. Global Coagulation Factor VIIa Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Coagulation Factor VIIa Revenue Market Share by Company (2019-2024)

Table 7. Global Coagulation Factor VIIa Sales Volume by Company (2019-2024) & (MT)

Table 8. Global Coagulation Factor VIIa Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Coagulation Factor VIIa Price by Company (2019-2024) & (USD/Kg)

Table 10. Key Manufacturers Coagulation Factor VIIa Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Coagulation Factor VIIa Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Coagulation Factor VIIa

Table 13. Global Coagulation Factor VIIa Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coagulation Factor VIIa as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Coagulation Factor VIIa Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Coagulation Factor VIIa Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Coagulation Factor VIIa Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Coagulation Factor VIIa Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Coagulation Factor VIIa Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Coagulation Factor VIIa Sales Volume by Type: 2019 VS 2023 VS 2030 (MT)

Table 22. Global Coagulation Factor VIIa Sales Volume by Type (2019-2024) & (MT)

Table 23. Global Coagulation Factor VIIa Sales Volume by Type (2025-2030) & (MT)

Table 24. Global Coagulation Factor VIIa Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Coagulation Factor VIIa Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Coagulation Factor VIIa Price by Type (2019-2024) & (USD/Kg)

Table 27. Global Coagulation Factor VIIa Price by Type (2025-2030) & (USD/Kg)

Table 28. Global Coagulation Factor VIIa Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Coagulation Factor VIIa Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Coagulation Factor VIIa Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Coagulation Factor VIIa Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Coagulation Factor VIIa Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Coagulation Factor VIIa Sales Volume by Application: 2019 VS 2023 VS 2030 (MT)

Table 34. Global Coagulation Factor VIIa Sales Volume by Application (2019-2024) & (MT)

Table 35. Global Coagulation Factor VIIa Sales Volume by Application (2025-2030) & (MT)

Table 36. Global Coagulation Factor VIIa Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Coagulation Factor VIIa Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Coagulation Factor VIIa Price by Application (2019-2024) & (USD/Kg)

Table 39. Global Coagulation Factor VIIa Price by Application (2025-2030) & (USD/Kg)

Table 40. Global Coagulation Factor VIIa Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Coagulation Factor VIIa Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Coagulation Factor VIIa Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Coagulation Factor VIIa Sales Value by Region (2019-2024) & (%)

Table 44. Global Coagulation Factor VIIa Sales Value by Region (2025-2030) & (%)

Table 45. Global Coagulation Factor VIIa Sales Volume by Region (MT): 2019 VS 2023 VS 2030

Table 46. Global Coagulation Factor VIIa Sales Volume by Region (2019-2024) & (MT)

Table 47. Global Coagulation Factor VIIa Sales Volume by Region (2025-2030) & (MT)

Table 48. Global Coagulation Factor VIIa Sales Volume by Region (2019-2024) & (%)

Table 49. Global Coagulation Factor VIIa Sales Volume by Region (2025-2030) & (%)

Table 50. Global Coagulation Factor VIIa Average Price by Region (2019-2024) & (USD/Kg)

Table 51. Global Coagulation Factor VIIa Average Price by Region (2025-2030) & (USD/Kg)

Table 52. Key Countries/Regions Coagulation Factor VIIa Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Coagulation Factor VIIa Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Coagulation Factor VIIa Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Coagulation Factor VIIa Sales Volume, (2019-2024) & (MT)

Table 56. Key Countries/Regions Coagulation Factor VIIa Sales Volume, (2025-2030) & (MT)

Table 57. Novo Nordisk Company Information

Table 58. Novo Nordisk Introduction and Business Overview

Table 59. Novo Nordisk Coagulation Factor VIIa Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 60. Novo Nordisk Coagulation Factor VIIa Product Offerings

Table 61. Novo Nordisk Recent Development

Table 62. LFB SA HEMA Biologics Company Information

Table 63. LFB SA HEMA Biologics Introduction and Business Overview

Table 64. LFB SA HEMA Biologics Coagulation Factor VIIa Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 65. LFB SA HEMA Biologics Coagulation Factor VIIa Product Offerings

Table 66. LFB SA HEMA Biologics Recent Development

Table 67. AryoGen Pharmed Company Information

Table 68. AryoGen Pharmed Introduction and Business Overview

Table 69. AryoGen Pharmed Coagulation Factor VIIa Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 70. AryoGen Pharmed Coagulation Factor VIIa Product Offerings

Table 71. AryoGen Pharmed Recent Development

Table 72. GENERIUM Company Information

Table 73. GENERIUM Introduction and Business Overview

Table 74. GENERIUM Coagulation Factor VIIa Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 75. GENERIUM Coagulation Factor VIIa Product Offerings

Table 76. GENERIUM Recent Development

Table 77. Key Raw Materials Lists

Table 78. Raw Materials Key Suppliers Lists

Table 79. Coagulation Factor VIIa Downstream Customers

Table 80. Coagulation Factor VIIa Distributors List

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

List of Figures

Figure 1. Coagulation Factor VIIa Product Picture

Figure 2. Global Coagulation Factor VIIa Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Coagulation Factor VIIa Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Coagulation Factor VIIa Sales Volume (2019-2030) & (MT)

Figure 5. Global Coagulation Factor VIIa Sales Price (2019-2030) & (USD/Kg)

Figure 6. Coagulation Factor VIIa Report Years Considered

Figure 7. Global Coagulation Factor VIIa Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Coagulation Factor VIIa Players Sales Volume Ranking (2023) & (MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Coagulation Factor VIIa Revenue in 2023

Figure 10. Coagulation Factor VIIa Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Prefilled Syringe Picture

Figure 12. Vial Picture

Figure 13. Global Coagulation Factor VIIa Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Coagulation Factor VIIa Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Coagulation Factor VIIa Sales Volume by Type (2019 VS 2023 VS 2030) & (MT)

Figure 16. Global Coagulation Factor VIIa Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Coagulation Factor VIIa Price by Type (2019-2030) & (USD/Kg)

Figure 18. Product Picture of Congenital Hemophilia

Figure 19. Product Picture of Acquired Hemophilia

Figure 20. Product Picture of Other

Figure 21. Global Coagulation Factor VIIa Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Coagulation Factor VIIa Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Coagulation Factor VIIa Sales Volume by Application (2019 VS 2023 VS 2030) & (MT)

Figure 24. Global Coagulation Factor VIIa Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Coagulation Factor VIIa Price by Application (2019-2030) & (USD/Kg)

Figure 26. North America Coagulation Factor VIIa Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Coagulation Factor VIIa Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Coagulation Factor VIIa Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Coagulation Factor VIIa Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Coagulation Factor VIIa Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Coagulation Factor VIIa Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Coagulation Factor VIIa Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Coagulation Factor VIIa Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Coagulation Factor VIIa Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Coagulation Factor VIIa Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Coagulation Factor VIIa Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Coagulation Factor VIIa Sales Volume (%), (2019-2030)

Figure 38. United States Coagulation Factor VIIa Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Coagulation Factor VIIa Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Coagulation Factor VIIa Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Coagulation Factor VIIa Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Coagulation Factor VIIa Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Coagulation Factor VIIa Sales Value by Application (%), 2023 VS 2030

Figure 44. China Coagulation Factor VIIa Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Coagulation Factor VIIa Sales Value by Type (%), 2023 VS 2030

Figure 46. China Coagulation Factor VIIa Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Coagulation Factor VIIa Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Coagulation Factor VIIa Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Coagulation Factor VIIa Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Coagulation Factor VIIa Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Coagulation Factor VIIa Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Coagulation Factor VIIa Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Coagulation Factor VIIa Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Coagulation Factor VIIa Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Coagulation Factor VIIa Sales Value by Application (%), 2023 VS 2030

Figure 56. India Coagulation Factor VIIa Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Coagulation Factor VIIa Sales Value by Type (%), 2023 VS 2030

Figure 58. India Coagulation Factor VIIa Sales Value by Application (%), 2023 VS 2030

Figure 59. Coagulation Factor VIIa Industrial Chain

Figure 60. Coagulation Factor VIIa Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Eptacog Alfa Recombinant Human Coagulation Factor VIIa Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Activated Coagulation Factor VII Market Research Report 2025

Global Human Coagulation Factor VII Market Insights Forecast to 2030

Global Eptacog Alfa rFVIIa Market Research Report 2025

Coagulation Factors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Factor VIII Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Coagulation Factor Ⅷ for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biological Hemostatic Material Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Coagulation Factors Market Insights Forecast to 2030

Plasma derived Factor VIII Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Coagulation Factor Concentrate Market Research Report 2024

Thrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Coagulation Factor Ⅷ Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Antihemophilic Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Coagulation Factor IX Market Research Report 2025

Global Recombinant Human Thrombin for Surgical Hemostasis Market Research Report 2024

Blood Coagulation Factor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Coagulation Factor IX Market Research Report 2024

Global Topical Recombinant Thrombin Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-19A18322

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3E3525

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35T3049

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33Y1801

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Coagulation Factor VIIa - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-29K12025

Coagulation Factor VIIa - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Coagulation Factor VIIa - Market Size

Coagulation Factor VIIa - Market

Report Scope

Scope of Coagulation Factor VIIa - Market Report

Chapter Outline

FAQ for this report

What is the Coagulation Factor VIIa - Market size in 2028?

Who are the main players in the Coagulation Factor VIIa - Market report?

What are the Application segmentation covered in the Coagulation Factor VIIa - Market report?

What are the Type segmentation covered in the Coagulation Factor VIIa - Market report?

Recommended Reports

Coagulation Factors

Hemostasis Devices

Diagnostic Analyzers

FEATURED COMPANIES

RELATED REPORTS